| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.87B | 159.37B | 164.08B | 164.97B | 136.93B | 136.09B |
| Gross Profit | 28.32B | 28.35B | 26.83B | 25.47B | 24.19B | 24.80B |
| EBITDA | 20.79B | 20.98B | 19.78B | 19.10B | 18.42B | 19.41B |
| Net Income | 12.31B | 12.86B | 11.86B | 11.24B | 11.04B | 11.29B |
Balance Sheet | ||||||
| Total Assets | 210.30B | 216.57B | 211.20B | 194.78B | 173.00B | 170.03B |
| Cash, Cash Equivalents and Short-Term Investments | 22.54B | 16.83B | 24.99B | 25.14B | 23.46B | 19.60B |
| Total Debt | 33.50B | 34.50B | 28.50B | 21.44B | 9.42B | 16.59B |
| Total Liabilities | 81.42B | 87.48B | 83.17B | 77.13B | 62.20B | 66.08B |
| Stockholders Equity | 128.88B | 129.09B | 124.41B | 114.30B | 107.78B | 101.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.39B | -4.63B | -7.14B | 13.34B | -5.38B |
| Operating Cash Flow | 0.00 | -2.17B | -1.64B | -4.35B | 17.07B | 195.00M |
| Investing Cash Flow | 0.00 | -1.98B | -972.00M | -1.84B | -3.47B | -5.99B |
| Financing Cash Flow | 0.00 | -3.70B | 2.52B | 7.85B | -9.78B | 2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥116.84B | 10.36 | ― | 3.81% | 0.82% | 30.84% | |
77 Outperform | ¥40.47B | 6.66 | ― | 3.88% | 4.11% | 28.37% | |
76 Outperform | ¥190.03B | 10.32 | ― | 3.44% | 11.25% | 36.92% | |
75 Outperform | ¥129.12B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
70 Outperform | ¥15.33B | 6.90 | ― | 1.39% | 2.98% | 11.88% | |
68 Neutral | ¥150.33B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |